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M UL TIPLE organ-system failure (MOSF) is a well-recognized entity 
responsible for a high mortality in pediatric 
patients in the intensive care unit. I MOSF 
implies the failure of at least two organs,I,2 
and although the etiology is not clear, sepsis is 
a common denominator.3 
Liver transplantation is the treatment of 
choice for patients with end-stage liver dis-
ease.4 The impact of preoperative MOSF on 
survival after liver transplantation is not 
known. In some patients MOSF may develop 
in the terminal stages of liver failure, and in 
such patients sepsis may not be present. 
Another group includes patients who develop 
MOSF before retransplantation due to failure 
of the primary graft. In this latter group sepsis 
is almost always present, such as from intra-
hepatic abscess following thrombosis of the 
hepatic artery and cholangitis due to biliary 
strictures.5,6 
The purpose of this investigation was to 
study survival after liver replacement (pri-
mary or retransplantation) in pediatric 
patients with MOSF. 
METHODS 
A retrospective analysis was made of the medical 
records of 144 children «18 years of age) who received 
hepatic transplantation at Children's Hospital of Pitts-
burgh from july 1, 1984 to June 30, 1986. Twenty-two 
patients were confirmed as having MOSF before primary 
grafting or retransplantation using the criteria for organ 
failure described by Wilkinson et ai, I except that in our 
study renal failure was defined as creatine greater than 1 
mg/dL and/or BUN greater than 100 mg/dL. The other 
difference was that all our MOSF patients had two or 
more organs failing simultaneously at the time of trans-
plantation. Data pertaining to the cardiovascular, respira-
tory, neurologic, hematologic, and renal systems were 
recorded. Mortality was defined as that occurring in 
hospital. 
RESULTS 
Twenty-two patients had MOSF before 
undergoing primary grafting or retransplan-
tation. The 11 boys and 11 girls ranged in age 
from 4 months to 15 years (mean, 49 months); 
six patients were younger than I year. The 
weight ranged from 5.3 kg to 47 kg (mean, 15 
kg). 
Nine patients had MOSF before primary 
transplantation, and in the other 13 patients 
MOSF developed after the primary allograft 
failed and before retransplantation. 
The diagnostic indications for hepatic 
replacement are listed in Table 1. The precipi-
tating causes of MOSF were liver dysfunction 
or intrahepatic sepsis (13 cases), extrahepatic 
sepsis (five cases), CNS disorders (two cases), 
renal failure (one case), and undetermined 
(two cases). At the time of surgery ten 
patients had failure of two organ systems, and 
12 patients had failure of three or more organ 
systems. Liver failure was present in 20 
patients, CNS failure in 12, respiratory sys-
tem failure in six, cardioVascular system fail-
ure in six, and renal failure in five. 
SURVIVAL 
Nine of the 22 patients (40%) survived. 
Survival was 55% (five of nine patients) In 
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Table 1. Disease Indications for Hepatic Replacement 
Disease 
Biliary atresia 
Fulminant hepatitis 
Alpha-1-antitrypsin deficiency 
Glycogen storage disease 
Tyrosinemia 
Cystinosis 
Other 
No. of 
Patients 
11 
4 
1 
3 
patients undergoing first transplants and 30% 
(four of 13 patients) in patients undergoing 
retransplantation. Survival was 60% (six of 
ten) in patients with failure of two organ 
systems and 25% (three of 12) in patients with 
failure of three or more organ systems. 
The number of major complications also 
paralleled survival. Two of three patients with 
no postoperative complications survived, but 
only four of 17 patients with four or more 
major complications survived. 
The average hospital stay was 67 days, 42 
days for nonsurvivors and 102 days for survi-
vors. 
DISCUSSION 
MOSF is a well-recognized entity in surgi-
cal patients after severe trauma or postopera-
tive complications.3,7 Mortality varies from 
57% to 100% in the population at risk, 
depending on the number of failing organ 
systems.' Similar findings were observed by 
Wilkinson et ai,' in a study of pediatric 
patients with MOSF. They reported an over-
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all survival rate of 46% in 226 patients with 
failure of two or more organ systems. Mortal-
ity increased according to the number of fail-
ing systems and reached 75% in patients with 
four failing systems.' 
Patients with chronic liver failure are debil-
itated and prone to complications; therefore it 
is not surprising that MOSF developed in 
several patients awaiting hepatic transplanta-
tion. It is also expected that in such debilitated 
patients MOSF would develop after failure of 
the first allograft, particularly in the presence 
of infection. What is not clear is whether 
MOSF is a contraindication for liver trans-
plantation. In the present investigation there 
is a direct correlation between the number of 
failing organ systems and the mortality; nev-
ertheless nine (40%) children with MOSF 
survived. Therefore MOSF per se is not an 
absolute contraindication to hepatic trans-
plantation. 
Since the availability of pediatric livers is 
limited, the use of such organs in patients with 
three or more failing organ systems should be 
carefully scrutinized. If intrinsic liver disease 
is the cause of MOSF, replacing the diseased 
liver may be a reasonable approach (Matus-
chak GM, Shaw BW Jr, unpublished observa-
tions). On the other hand, if the cause of 
MOSF is extrahepatic, the indications for 
liver replacement are less clear, and a prospec-
tive study is needed to establish guidelines for 
the proper allocation of organs in patients 
with liver disease and MOSF due to extrahe-
patic causes. 
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